Mannan immunoassay for diagnosis of invasive mucormycosis: assay development, preclinical testing and evaluation in an animal model

By afschroeder • August 7, 2026

Burnham-Marusich AR, Pandit V, Alkhazraji S, Gu Y, Zayac KR, Wingard JR, Culver EL, Walish JJ, Ibrahim AS, Kozel TR. Mannan immunoassay for diagnosis of invasive mucormycosis: assay development, preclinical testing and evaluation in an animal model. Front Cell Infect Microbiol. 2026 Jul 22;16:1875264. doi: 10.3389/fcimb.2026.1875264. PMID: 42558287; PMCID: PMC13437415.

Tags: Biomarker, diagnostic, Harbor UCLA, Infectious Diseases, invasive fungal disease, lateral flow immunoassay, mannan, mucormycosis, point of care, Publications, rapid test

Early-Onset Gastric Cancer as a High-Risk Disease Entity in the United States: Clinicopathologic Features, Regional Variation, and Outcomes

Castillo DR, Shah P, Tai D, Guo M, Hazeltine M, Guzman S, Park D, Mannan R, Xing Y, Brar G, Raoof M, Eng C, Wu[...]

Women and Herpes Zoster in the United States: Risk and Prevention Management-A Narrative Review

Campos R, Caldera F, Carrico J, Cochrane C, Eltoukhy N, Huang C, Kneller S, Rutland C, Slovis J. Women and Herpes Zoster in the United[...]

Response to the Letter to the Editor Entitled “Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy”

Giri K, Glassock RJ, Fervenza FC. Response to the Letter to the Editor Entitled "Critical Reappraisal of Obinutuzumab Randomized Trials in Membranous Nephropathy". Kidney Int[...]